KURA Kura Oncology, Inc. gains 61% May 13, 2020
Developing in-licensed protein inhibitors for solid tumors and blood cancers.http://www.priceseries.com/trade/KURA-Kura-Oncology-Inc-stock-gains-61-percent-a-Trade-Record-by-priceSeries-2020040820200513.html